Solvaypharmaceuticals-us.comNews RoomSolvay Pharmaceuticals, Inc. and Mayo Clinic Collaborate on Novel Concept for Treating Gastrointestinal Motility Disorders
This Site All Sites

 


 


 
 
 

> August 04, 2005<
 
Solvay Pharmaceuticals, Inc. and Mayo Clinic Collaborate on Novel Concept for Treating Gastrointestinal Motility Disorders

 

 

MARIETTA, Ga. - August 4, 2005 - Solvay Pharmaceuticals, Inc. announced today that it has signed a collaboration agreement with the Mayo Foundation for Medical Education and Research  to investigate a novel mechanism of action to treat gastrointestinal motility disorders.

Mayo granted licenses to Solvay Pharmaceuticals to use its patent rights for the development of products, processes and methods for public use for this mechanism of action. Once Mayo has completed confirmatory studies on the concept, the company will collaborate with Mayo to screen Solvay Pharmaceuticals’ pipeline molecules to identify those with a high affinity toward this mechanism of action.
 
“Solvay Pharmaceuticals and the Mayo have a long history of collaboration and we are pleased to explore this important concept together,” said Harold Shlevin, PhD., President and CEO of Solvay Pharmaceuticals, Inc. “This agreement is an integral part of the company’s commitment to developing innovative treatments for patients with gastrointestinal motility disorders.”

Gianrico Farrugia, M.D., Mayo Clinic gastroenterologist, will lead the research as the Principal Investigator under the agreement.  “Mayo is equally excited to collaborate with Solvay Pharmaceuticals to develop drug targets for gastrointestinal motility disorders,” stated Dr. Farrugia.

Solvay Pharmaceuticals, Inc. of Marietta, Ga. (USA) is a research-driven pharmaceutical company that seeks to fulfill unmet medical needs in the therapeutic areas of cardiology, gastroenterology, mental health, women's health and a select group of specialized markets including men's health.  It is a part of the global Solvay Pharmaceuticals organization whose core activities consist of discovering, developing and manufacturing medicines for human use.  Solvay Pharmaceuticals, Inc. is a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium.

 



 

 

 

 


| Email this |

 

 

 

 

 

accueil
© Solvay Pharmaceuticals, Inc. • Important information : Privacy Policy  -  Terms of Use • 
If you have any comments, please contact the webmaster
Date of last update: 6/26/2008